Zepp Health Net Worth
Zepp Health Net Worth Breakdown | ZEPP |
Zepp Health Net Worth Analysis
Zepp Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Zepp Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Zepp Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Zepp Health's net worth analysis. One common approach is to calculate Zepp Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Zepp Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Zepp Health's net worth. This approach calculates the present value of Zepp Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Zepp Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Zepp Health's net worth. This involves comparing Zepp Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Zepp Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Zepp Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zepp Health's net worth research are outlined below:
Zepp Health Corp is way too risky over 90 days horizon | |
Zepp Health Corp appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 182.6 M. Net Loss for the year was (75.81 M) with profit before overhead, payroll, taxes, and interest of 69.89 M. | |
Zepp Health Corp currently holds about 996.59 M in cash with (24.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Latest headline from gurufocus.com: NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador ZEPP Stock News |
Zepp Health Quarterly Good Will |
|
Zepp Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zepp Health Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zepp Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
19th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Zepp Health Target Price Consensus
Zepp target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Zepp Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
One | Strong Buy |
Most Zepp analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Zepp stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Zepp Health Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationZepp Health Target Price Projection
Zepp Health's current and average target prices are 13.04 and 12.32, respectively. The current price of Zepp Health is the price at which Zepp Health Corp is currently trading. On the other hand, Zepp Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Zepp Health Market Quote on 21st of July 2025
Target Price
Analyst Consensus On Zepp Health Target Price
Know Zepp Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zepp Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zepp Health Corp backward and forwards among themselves. Zepp Health's institutional investor refers to the entity that pools money to purchase Zepp Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Rialto Wealth Management, Llc | 2025-03-31 | 1000 | Sbi Securities Co Ltd | 2025-03-31 | 941 | Advisor Group Holdings, Inc. | 2025-03-31 | 575 | Rhumbline Advisers | 2025-03-31 | 529 | Jpmorgan Chase & Co | 2025-03-31 | 236 | Lazard Asset Management Llc | 2025-03-31 | 157 | Royal Bank Of Canada | 2024-12-31 | 100.0 | Bank Of America Corp | 2025-03-31 | 62.0 | Mccormack Advisors International | 2025-03-31 | 53.0 | Allspring Global Investments Holdings, Llc | 2025-03-31 | 854.3 K | Fidelity International Ltd | 2025-03-31 | 719.5 K |
Follow Zepp Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 189.52 M.Market Cap |
|
Project Zepp Health's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.15) | (0.14) | |
Return On Capital Employed | (0.14) | (0.13) | |
Return On Assets | (0.14) | (0.14) | |
Return On Equity | (0.30) | (0.29) |
When accessing Zepp Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Zepp Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Zepp Health's profitability and make more informed investment decisions.
Evaluate Zepp Health's management efficiency
Zepp Health Corp has return on total asset (ROA) of (0.0565) % which means that it has lost $0.0565 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2856) %, meaning that it created substantial loss on money invested by shareholders. Zepp Health's management efficiency ratios could be used to measure how well Zepp Health manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/21/2025, Return On Tangible Assets is likely to grow to -0.14. In addition to that, Return On Capital Employed is likely to grow to -0.13. As of 07/21/2025, Total Current Liabilities is likely to drop to about 185.6 M. In addition to that, Liabilities And Stockholders Equity is likely to drop to about 502.2 MLast Reported | Projected for Next Year | ||
Book Value Per Share | 15.62 | 18.62 | |
Tangible Book Value Per Share | 14.59 | 17.51 | |
Enterprise Value Over EBITDA | (2.81) | (2.67) | |
Price Book Value Ratio | 0.04 | 0.04 | |
Enterprise Value Multiple | (2.15) | (2.04) | |
Price Fair Value | 0.04 | 0.04 | |
Enterprise Value | 2.9 B | 2.7 B |
Effective leadership at Zepp Health drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 1.6436 | Revenue | Quarterly Revenue Growth (0.03) | Revenue Per Share | Return On Equity |
Zepp Health Corporate Filings
18th of July 2025 Other Reports | ViewVerify | |
14th of July 2025 Other Reports | ViewVerify | |
21st of May 2025 Other Reports | ViewVerify | |
6K | 20th of May 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
Zepp Health Earnings Estimation Breakdown
The calculation of Zepp Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Zepp Health is estimated to be -0.035 with the future projection ranging from a low of -0.035 to a high of -0.035. Please be aware that this consensus of annual earnings estimates for Zepp Health Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.04 Lowest | Expected EPS | -0.04 Highest |
Zepp Health Earnings Projection Consensus
Suppose the current estimates of Zepp Health's value are higher than the current market price of the Zepp Health stock. In this case, investors may conclude that Zepp Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Zepp Health's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
1 | -1.04% | -2.29 | -0.035 | -4.96 |
Zepp Health Earnings per Share Projection vs Actual
Actual Earning per Share of Zepp Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Zepp Health Corp predict the company's earnings will be in the future. The higher the earnings per share of Zepp Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Zepp Health Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Zepp Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Zepp Health should always be considered in relation to other companies to make a more educated investment decision.Zepp Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Zepp Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2025-05-20 | 2025-03-31 | 0 | -1.23 | -1.23 | 0 | ||
2025-03-26 | 2024-12-31 | 0.4096 | -2.29 | -2.6996 | 659 | ||
2024-11-12 | 2024-09-30 | 0.2985 | -0.8205 | -1.119 | 374 | ||
2024-08-21 | 2024-06-30 | 0.04 | -0.1665 | -0.2065 | 516 | ||
2024-05-20 | 2024-03-31 | -0.03 | -0.2263 | -0.1963 | 654 | ||
2024-03-18 | 2023-12-31 | 0.3 | 0.06 | -0.24 | 80 | ||
2023-11-20 | 2023-09-30 | 0.23 | 0.05 | -0.18 | 78 | ||
2023-08-21 | 2023-06-30 | 0.09 | -0.97 | -1.06 | 1177 | ||
2023-05-23 | 2023-03-31 | -0.17 | -1.84 | -1.67 | 982 | ||
2023-03-21 | 2022-12-31 | 0.04 | -0.14 | -0.18 | 450 | ||
2022-11-21 | 2022-09-30 | 3.86 | -0.14 | -4.0 | 103 | ||
2022-08-25 | 2022-06-30 | -1.32 | -1.54 | -0.22 | 16 | ||
2022-05-24 | 2022-03-31 | 0.39 | 1.21 | 0.82 | 210 | ||
2022-03-17 | 2021-12-31 | 2.36 | 0.79 | -1.57 | 66 | ||
2021-11-16 | 2021-09-30 | 1.57 | 0.98 | -0.59 | 37 | ||
2021-08-19 | 2021-06-30 | 1.5 | 2.01 | 0.51 | 34 | ||
2021-05-13 | 2021-03-31 | 0.49 | -0.46 | -0.95 | 193 | ||
2021-03-15 | 2020-12-31 | 1.43 | 1.96 | 0.53 | 37 | ||
2020-11-23 | 2020-09-30 | 2.62 | 1.85 | -0.77 | 29 | ||
2020-08-18 | 2020-06-30 | 0.35 | 0.3 | -0.05 | 14 | ||
2020-05-12 | 2020-03-31 | 1.17 | 0.39 | -0.78 | 66 | ||
2020-03-13 | 2019-12-31 | 3.04 | 3.31 | 0.27 | 8 | ||
2019-11-12 | 2019-09-30 | 2.7 | 3.25 | 0.55 | 20 | ||
2019-08-19 | 2019-06-30 | 1.72 | 1.73 | 0.01 | 0 | ||
2019-06-03 | 2019-03-31 | 0.64 | 1.49 | 0.85 | 132 | ||
2019-03-14 | 2018-12-31 | 1.28 | 2.3 | 1.02 | 79 | ||
2018-11-26 | 2018-09-30 | 0.39 | 0.45 | 0.06 | 15 | ||
2018-08-20 | 2018-06-30 | 0.88 | 1.61 | 0.73 | 82 | ||
2018-05-21 | 2018-03-31 | 0.77 | 1.56 | 0.79 | 102 | ||
2018-03-27 | 2017-12-31 | 0.92 | 1.48 | 0.56 | 60 | ||
2017-11-29 | 2017-09-30 | 0 | 0.12 | 0.12 | 0 | ||
2017-05-04 | 2017-03-31 | 0 | -0.06 | -0.06 | 0 |
Zepp Health Corporate Management
Xiaojun Zhang | VP Resources | Profile | |
Hui Wang | Vice President of Corporate Strategy and General Manager of Beijing Operations | Profile | |
Jimmy Lai | Independent Director | Profile | |
Hongjiang Zhang | Independent Director | Profile | |
De Liu | Director | Profile |
Already Invested in Zepp Health Corp?
The danger of trading Zepp Health Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zepp Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zepp Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zepp Health Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Zepp Stock Analysis
When running Zepp Health's price analysis, check to measure Zepp Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zepp Health is operating at the current time. Most of Zepp Health's value examination focuses on studying past and present price action to predict the probability of Zepp Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zepp Health's price. Additionally, you may evaluate how the addition of Zepp Health to your portfolios can decrease your overall portfolio volatility.